Table 2

Clinical characteristics of four quartiles of FMD

 FMD quartiles 
Quartile 1Quartile 2Quartile 3Quartile 4
≤3.94.0–5.85.9–7.9≥8.0
Variables(n=1329)(n=1329)(n=1328)(n=1328)p Value
Age (years)50.6±13.247.7±12.844.8±12.942.0±12.8<0.001
Body Mass Index, kg/m223.5±3.323.2±3.223.0±3.322.3±3.2<0.001
Systolic blood pressure, mm Hg128.5±18.5125.9±17.1123.6±16.3120.5±15.9<0.001
Diastolic blood pressure, mm Hg77.8±13.177.2±13.075.6±12.573.9±12.8<0.001
Heart rate, bpm64.1±11.063.9±10.963.4±10.064.6±9.90.03
Total cholesterol, mmol/L5.30±0.895.29±0.875.25±0.895.18±0.860.01
Triglycerides, mmol/L1.57±1.201.48±1.051.38±0.901.29±1.01<0.001
HDL cholesterol, mmol/L1.55±0.431.55±0.411.57±0.401.61±0.420.01
LDL cholesterol, mmol/L3.20±0.893.21±0.773.20±0.783.14±0.780.14
Glucose, mmol/L5.73±1.645.59±1.175.46±0.855.35±0.83<0.001
HbA1c, %5.24±0.755.17±0.575.10±0.525.04±0.46<0.001
Framingham Risk score4.36±4.343.37±4.832.08±5.420.57±6.39<0.001
Baseline brachial artery diameter, mm4.32±0.614.11±0.533.92±0.533.66±0.52<0.001
FMD, %2.33±1.404.97±0.546.94±0.5910.41±2.23<0.001
Hypertension, n (%)331 (25.1)196 (14.8)133 (10.0)78 (5.9)<0.001
Dyslipidemia, n (%)655 (49.6)598 (45.2)539 (40.6)472 (35.8)<0.001
Diabetes mellitus, n (%)134 (10.2)91 (6.9)67 (5.1)44 (3.3)<0.001
Smoking, n (%)461 (35.1)407 (30.9)346 (26.1)281 (21.4)<0.001
Coronary heart disease, n (%)47 (3.6)30 (2.3)24 (1.8)16 (1.3)<0.001
Cerebrovascular disease, n (%)20 (1.9)12 (1.1)8 (0.7)6 (0.5)0.01
  • p Values for comparisons across the quartiles of FMD were performed with ANOVA for continuous variables and χ2 test for categorical variables.

  • FMD, flow-mediated vasodilation; HDL, high-density lipoprotein cholesterol; LDL, low-density lipoprotein cholesterol.